PE20161402A1 - Feromona tranquilizadora para gatos - Google Patents

Feromona tranquilizadora para gatos

Info

Publication number
PE20161402A1
PE20161402A1 PE2016001646A PE2016001646A PE20161402A1 PE 20161402 A1 PE20161402 A1 PE 20161402A1 PE 2016001646 A PE2016001646 A PE 2016001646A PE 2016001646 A PE2016001646 A PE 2016001646A PE 20161402 A1 PE20161402 A1 PE 20161402A1
Authority
PE
Peru
Prior art keywords
methyl
cats
compositions
tranquilizing
pheromone
Prior art date
Application number
PE2016001646A
Other languages
English (en)
Inventor
Patrick Pageat
Original Assignee
Inst De Rech En Semiochimie Et Ethologie Appliquee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst De Rech En Semiochimie Et Ethologie Appliquee filed Critical Inst De Rech En Semiochimie Et Ethologie Appliquee
Publication of PE20161402A1 publication Critical patent/PE20161402A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D99/00—Subject matter not provided for in other groups of this subclass
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Steroid Compounds (AREA)
  • Feed For Specific Animals (AREA)

Abstract

Se refiere a composiciones que comprenden palmitato de metilo, linoleato de metilo, oleato de metilo, estearato de metilo, laurato de metilo y miristato de metilo, o sales de los mismos, y opcionalmente un vehiculo aceptable. En un aspecto preferido, dichas composiciones son topicas. Dichas composiciones tienen efecto tranquilizador en gatos, por lo cual son utiles para el tratamiento del estres, la ansiedad, la agresividad, y la adaptabilidad social de gatos
PE2016001646A 2014-03-18 2015-03-17 Feromona tranquilizadora para gatos PE20161402A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201461954771P 2014-03-18 2014-03-18

Publications (1)

Publication Number Publication Date
PE20161402A1 true PE20161402A1 (es) 2016-12-29

Family

ID=53385673

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2016001646A PE20161402A1 (es) 2014-03-18 2015-03-17 Feromona tranquilizadora para gatos

Country Status (22)

Country Link
US (1) US10258594B2 (es)
EP (1) EP3119410B1 (es)
JP (1) JP6629286B2 (es)
CN (2) CN106456590A (es)
AU (1) AU2015233067B2 (es)
CA (1) CA2943080C (es)
CL (1) CL2016002363A1 (es)
CY (1) CY1125380T1 (es)
DK (1) DK3119410T3 (es)
ES (1) ES2923675T3 (es)
HR (1) HRP20220957T1 (es)
HU (1) HUE059637T2 (es)
LT (1) LT3119410T (es)
MX (1) MX2016012112A (es)
PE (1) PE20161402A1 (es)
PL (1) PL3119410T3 (es)
PT (1) PT3119410T (es)
RU (1) RU2671858C2 (es)
SI (1) SI3119410T1 (es)
SM (1) SMT202200313T1 (es)
WO (1) WO2015140631A1 (es)
ZA (1) ZA201606607B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110917241A (zh) * 2019-12-13 2020-03-27 苏州弗艾柏生物科技有限公司 一种猫安抚信息素及其用途
FR3117731A1 (fr) 2020-12-21 2022-06-24 Virbac Dispositifs portables pour animaux de compagnie avec diffusion passive de compositions sémiochimiques
CN112826846A (zh) * 2020-12-31 2021-05-25 武汉研欣生物科技有限公司 猫用安抚信息素及其制备方法与应用
FR3119315B1 (fr) 2021-02-02 2022-12-30 Virbac « gel diffuseur de pheromones »
CN115282128B (zh) * 2022-08-02 2024-03-19 上海弗艾柏生物科技有限公司 猫面部信息素凝胶球及其制备方法
CN116763796B (zh) * 2023-06-20 2024-07-05 咪咪聊(武汉)生物科技有限公司 一种猫用信息素及猫用信息素混合物的制备方法和应用
CN120938981A (zh) * 2025-10-20 2025-11-14 宁波三生生物科技股份有限公司 一种信息素组合物及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426333B1 (en) 1996-09-19 2002-07-30 Merial Spot-on formulations for combating parasites
ATE185046T1 (de) * 1995-02-03 1999-10-15 Fideline Eigenschaften von gesichtpheromonen von katzen
US6054481A (en) 1998-01-21 2000-04-25 Fideline Pig appeasing pheromones for enhancing weight gain in a mammal
NO308197B1 (no) 1998-01-21 2000-08-14 Fideline Sammensetning og oppløsning derav for Õ minske stress, angst og agressivitet hos pattedyr inneholdende en blanding av fettsyrer eller derivater derav
FR2795960B1 (fr) 1999-07-05 2001-10-19 Sanofi Elf Microemulsions stables pour l'administration d'acides gras a l'homme ou a l'animal, et utilisation de ces microemulsions
JP2003313104A (ja) 2002-04-22 2003-11-06 Nippon Kayaku Co Ltd 動物の外部寄生虫駆除用スポットオン剤
ATE468123T1 (de) * 2002-06-19 2010-06-15 Fideline Beruhigende vogel-pheromone zur verminderung von stress, angst und aggressivität
DE60332635D1 (de) 2002-06-19 2010-07-01 Fideline Le Rieu Neuf Beruhigende vogel-pheromone zur verminderung von stress, angst und aggressivität
EP1670433B1 (en) 2003-10-10 2011-11-23 Antares Pharma IPL AG Transdermal pharmaceutical formulation for minimizing skin residues
FR2931676B1 (fr) 2008-05-30 2011-01-14 Ceva Sante Animale Nouveaux modes d'administration d'un melange d'acides gras pour le traitement de mammiferes non humains
EP2515647B1 (en) * 2009-12-21 2014-01-29 Sergeant's Pet Care Products, Inc. Pheromone compositions and methods of use

Also Published As

Publication number Publication date
AU2015233067A1 (en) 2016-10-20
LT3119410T (lt) 2022-08-25
PT3119410T (pt) 2022-07-22
CN114732810A (zh) 2022-07-12
SMT202200313T1 (it) 2022-09-14
CA2943080A1 (en) 2015-09-24
WO2015140631A1 (en) 2015-09-24
HRP20220957T1 (hr) 2022-10-28
MX2016012112A (es) 2017-04-06
CN106456590A (zh) 2017-02-22
RU2016137349A3 (es) 2018-04-25
CL2016002363A1 (es) 2017-07-21
US20180169054A1 (en) 2018-06-21
ZA201606607B (en) 2019-12-18
EP3119410A1 (en) 2017-01-25
JP2017508814A (ja) 2017-03-30
NZ724716A (en) 2022-03-25
US10258594B2 (en) 2019-04-16
HUE059637T2 (hu) 2022-12-28
CY1125380T1 (el) 2025-05-09
SI3119410T1 (sl) 2022-10-28
RU2016137349A (ru) 2018-04-18
PL3119410T3 (pl) 2022-09-12
CA2943080C (en) 2023-01-17
AU2015233067B2 (en) 2020-10-22
EP3119410B1 (en) 2022-05-04
DK3119410T3 (da) 2022-08-08
RU2671858C2 (ru) 2018-11-07
BR112016021430A2 (pt) 2017-08-15
JP6629286B2 (ja) 2020-01-15
ES2923675T3 (es) 2022-09-29

Similar Documents

Publication Publication Date Title
PE20161402A1 (es) Feromona tranquilizadora para gatos
IL249061B (en) Combination, composition, and method of administering the combination or composition to animals
CL2017000240A1 (es) Compuestos activos hacia bromodominios
CL2016000045A1 (es) Compuestos de n,6-bis(aril o heteroaril)-1,3,5-triazin-2,4-diamina como inhibidores de idh2 mutantes para el tratamiento de cáncer.
MX2021014617A (es) Mitigantes quimicos en alimento para animales e ingredientes alimentarios.
CL2016000017A1 (es) Carboxamidas de anillo de 4 miembros empleadas como nematicidas
MX2016002077A (es) Inhibidores de la proteína regulada por glucosa 94 (gpr94) selectivos y usos de los mismos.
UY35210A (es) Inhibidores de autotaxina
NI201600071A (es) Compuestos de inhibidor de autotaxina
UY36224A (es) Compuestos tricíclicos de imidazo-pirimidinona
CL2016001587A1 (es) Derivado basado en 1,2-naftoquinona y método de preparación del mismo.
MX2015014713A (es) Uso de una composicion que comprende aceite de pescado y jugo para el tratamiento y/o postratamiento de cancer.
CL2015003343A1 (es) Composición farmacéutica que comprende un agente terapéutico modificado en base a hemoglobina, para el tratamiento para tratar el cáncer, e imágenes de diagnóstico.
AR093011A1 (es) Alimento para animales que reduce las concentraciones de amoniaco en sus excrementos
CL2016001098A1 (es) Uso de cisteamina y sus derivados para el tratamiento de enfermedades mitocondriales
CL2017001025A1 (es) Compuestos para usarse en el tratamiento antihelmíntico
CL2018000451A1 (es) Composiciones de micropartículas que comprenden saflufenacil
NI201600070A (es) Inhibidores tetracíclicos de autotaxina
CL2016002779A1 (es) Composición para el cuidado de la piel
MX385899B (es) Plantas de lechuga que comprenden resistencia contra el biotipo 1 de nasonovia ribisnigri.
ECSP16096831A (es) Derivados de naftiridinadiona
MX2015009277A (es) Formas de dosificacion y usos terapauticos de l-4-cloro quinurenina.
MX2015012455A (es) Metodo para el tratamiento de la enfermedad de higado graso.
UY35390A (es) Compuestos con actividad anti-hcv y composiciones farmacéuticas que los contienen
BR112015024877A2 (pt) vacinas que compreendem polipeptídeos de leishmania para o tratamento e diagnóstico de leishmaniose